Fosaprepitant Intravenous and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Fosaprepitant Intravenous and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant Intravenous-Insulin glargine, recombinant Subcutaneous
- Fosaprepitant Intravenous-Insulin glulisine
- Fosaprepitant Intravenous-Insulin Glulisine (Cartridges and Pens)
- Fosaprepitant Intravenous-Insulin Glulisine (Vials)
- Fosaprepitant Intravenous-Insulin glulisine Subcutaneous
- Fosaprepitant Intravenous-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Foscarnet
- Insulin glargine and lixisenatide Subcutaneous-Foscarnet Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Foscarnet Sodium
- Insulin glargine and lixisenatide Subcutaneous-Foscavir
- Insulin glargine and lixisenatide Subcutaneous-Fosfomycin
- Insulin glargine and lixisenatide Subcutaneous-Fosfomycin Tromethamine